We are international
Donate
• IMF TV TEXT SIZE   
Ask Dr. Durie    back

#AskDrDurie: If Myeloma Is Diagnosed, Is It Okay to Start With A Holistic Type of Approach First?
05.01.14

Be the first to comment

 related articles
What is the new Blac...
What is this new Bla...
Is it worth the risk...
How long does it tak...
How common are low p...
Does immune therapy ...
Do all myeloma patie...
What is the status o...
If no treatment for ...
After relapse, I’m r...
Is it possible to ha...
What are the new dru...
How does one achieve...
What are the key, on...
What are the best sc...
Can myeloma progress...
Will any of the newl...
What Should we know ...
What should we know ...
What should we know ...
What is Ixazomib?
Can DDT exposure cau...
Can you help make se...
What does it mean to...
Do bone lesions rege...
Do African Americans...
How does the IMF hel...
Are statins helpful ...
What is the role of ...
What is the latest n...
What is Selinexor?
What are myeloma ste...
How quickly will you...
What does the deleti...
Should all myeloma p...
Can weakness, dizzin...
Should you have a st...
How do I find a myel...
What kinds of scan c...
How common is toxopl...
What are the practic...
Whats the latest upd...
Is the combination o...
Are veterans with my...
How does myeloma aff...
What is IVIG?
Is chiropractic care...
Does pomalidomide wo...
When will the first ...
If stringent complet...
What are myeloma tre...
Does the type of mye...
Dr. Durie, what is y...
What is the recommen...
What is the typical ...
What are some treatm...
What does ‘dysplasia...
Should gadolinium be...
What is the M protei...
If bone density is l...
What is the 17p dele...
#AskDrDurie: What’s ...
#AskDrDurie: What do...
#AskDrDurie: Why was...
#AskDrDurie: What's...
#AskDrDurie: Can Cyt...
#AskDrDurie: What ha...
#AskDrDurie: Can the...
#AskDrDurie: Is it p...
#AskDrDurie: What is...
#AskDrDurie: How doe...
#AskDrDurie: What is...
#AskDrDurie: Is auto...
#AskDrDurie: Has the...
#AskDrDurie: If Poma...
#AskDrDurie: Is ther...
#AskDrDurie: How can...
#AskDrDurie: Is it o...
#AskDrDurie: What ar...
#AskDrDurie: Should ...
#AskDrDurie: How can...
#AskDrDurie: Can a l...
#AskDrDurie: Does ag...
#AskDrDurie: Is MRI ...
#AskDrDurie: Are the...
#AskDrDurie: Are cl...
#AskDrDurie: How doe...
#AskDrDurie: Are PET...
#AskDrDurie: In ligh...
#AskDrDurie: Should ...
#AskDrDurie: If Myel...
#AskDrDurie: My Mai...
#AskDrDurie: My Doc...
#AskDrDurie: Is Stop...
#AskDrDurie: Does "...
#AskDrDurie: If Mye...
#AskDrDurie: I Need ...
#AskDrDurie: Is Part...
#AskDrDurie: Can Mye...
#AskDrDurie: What Ab...
#AskDrDurie: What Is...
#AskDrDurie: What Is...
#AskDrDurie: Should ...
#AskDrDurie: How Can...
#AskDrDurie: Are The...
#AskDrDurie: Should ...
#AskDr.Durie: Is Che...
#AskDrDurie: What Di...
#AskDrDurie: What's ...
#AskDrDurie: Is MGUS...
#AskDrDurie: ASCT Fo...
#AskDrDurie: Can Zom...
#AskDrDurie: Are Cat...
#AskDrDurie: How Do ...
#AskDrDurie: Is Kidn...
#AskDrDurie: Which o...
#AskDrDurie: How clo...

What is the new Black Swan project that studies families with myeloma?
What is this new Black Swan project called iStopMM?
Is it worth the risk of developing a secondary cancer after ASCT?
How long does it take to assess if a particular treatment is working?
How common are low platelet counts after autologous stem cell transplant?
Does immune therapy work for high-risk myeloma?
Do all myeloma patients become high-risk at some point?
What is the status of the measles vaccine trial?
If no treatment for multiple myeloma is recommended, is a bone marrow biopsy necessary?
After relapse, I’m responding well to Rev/dex. Should I continue this treatment?
Is it possible to have symptoms of myeloma in your head?
What are the new drug trials available for patients in 2016?
How does one achieve a strong communicative relationship with one’s doctor?
What are the key, ongoing clinical trials for myeloma patients?
What are the best scans to monitor myeloma?
Can myeloma progress after an autologous stem cell transplant (ASCT)?
Will any of the newly FDA-approved drugs be available for frontline therapy?
What Should we know about FDA approval of Empliciti® (elotuzumab)?
What should we know about the FDA approval of Ninlaro® (ixazomib)?
What should we know about FDA approval of Darzalex® (daratumumab)?
What is Ixazomib?
Can DDT exposure cause myeloma?
Can you help make sense of statistics?
What does it mean to be MRD-negative if you have high-risk 17p- myeloma?
Do bone lesions regenerate?
Do African Americans have an increased risk of myeloma?
How does the IMF help accelerate new drug approvals?
Are statins helpful or harmful for myeloma patients?
What is the role of imaging for routine assessment of myeloma?
What is the latest news about the Black Swan Research Initiative?
What is Selinexor?
What are myeloma stem cells?
How quickly will you see a benefit from an autologous stem cell transplant?
What does the deletion of chromosome 17 mean?
Should all myeloma patients be screened for amyloidosis?
Can weakness, dizziness and other symptoms be caused by a Vitamin B12 deficiency?
Should you have a stem cell transplant even after a partial response to treatment?
How do I find a myeloma specialist in my area?
What kinds of scan can determine if bone pain indicates new myeloma disease?
How common is toxoplasmosis infection?
What are the practical details of FISH testing?
Whats the latest update on the Black Swan Research Initiative®?
Is the combination of Kyprolis, Cytoxan and dexamethasone available as a treatment?
Are veterans with myeloma a unique population?
How does myeloma affect the immune system?
What is IVIG?
Is chiropractic care an option for patients with myeloma?
Does pomalidomide work on a myeloma patient that has not had a response with other iMiDs?
When will the first monoclonal antibody be approved?
If stringent complete remission is achieved, is maintenance therapy still required?
What are myeloma treatment options for a patient with bipolar disorder?
Does the type of myeloma impact the choice of treatment?
Dr. Durie, what is your perspective on the discussion about the cost of cancer drugs?
What is the recommended use of Biaxin in patients with myeloma?
What is the typical speed of improvement in the Freelite and protein levels with myeloma treatment?
What are some treatment options for the t(4;14) abnormality?
What does ‘dysplasia’ mean within the bone marrow report?
Should gadolinium be used as part of MRI testing?
What is the M protein?
If bone density is low, does that mean myeloma is present?
What is the 17p deletion?
#AskDrDurie: What’s new with the Black Swan Research Initiative®?
#AskDrDurie: What does IMWG’s new diagnostic criteria mean for myeloma patients?
#AskDrDurie: Why wasn’t panobinostat approved?
#AskDrDurie: What's new at ASH 2014
#AskDrDurie: Can Cytoxan cause heart damage?
#AskDrDurie: What happens to stem cells once they are harvested?
#AskDrDurie: Can the Hevylite™ test be used to monitor IgA myeloma?
#AskDrDurie: Is it possible to have short remissions without high-risk features?
#AskDrDurie: What is remission?
#AskDrDurie: How does the IMF contribute to the myeloma community?
#AskDrDurie: What is Selinexor
#AskDrDurie: Is autologous stem cell transplant still recommended?
#AskDrDurie: Has there been any change in recommendations used to treat bone disease in myeloma?
#AskDrDurie: If Pomalyst does not produce a full response, what are my options?
#AskDrDurie: Is there a test available for measuring Minimal Residual Disease, what we call MRD?
#AskDrDurie: How can Revlimid’s diarrhea side effect be handled?
#AskDrDurie: Is it okay to take vitamin B12 on the same day as Velcade?
#AskDrDurie: What are the important aspects of different types of imaging, such as regular x-rays, MRI, CT, and PET?
#AskDrDurie: Should I have an ASCT if I've been through therapy and am in remission?
#AskDrDurie: How can myeloma suddenly go from standard to high risk?
#AskDrDurie: Can a low white blood cell count be enough to trigger a need for myeloma therapy?
#AskDrDurie: Does age make a difference in selecting myeloma treatment?
#AskDrDurie: Is MRI testing important to see if treatment is necessary for smoldering myeloma?
#AskDrDurie: Are there maintenance therapy recommendations for myeloma patients with t(4;14)?
#AskDrDurie: Are clinical trials part of the Black Swan Research Initiative(R), and if so, how can I participate?
#AskDrDurie: How does the new flow cytometry testing for MRD compare to molecular testing?
#AskDrDurie: Are PET/CT scans useful for a patient with MGUS?
#AskDrDurie: In light of Tom Brokaw's recent myeloma diagnosis, is better early screening required?"
#AskDrDurie: Should Patients With Similar Types of Myeloma Form Separate Support Groups?
#AskDrDurie: If Myeloma Is Diagnosed, Is It Okay to Start With A Holistic Type of Approach First?
#AskDrDurie: My Maintenance was Stopped Because the Side Effects were Too Bad. How Common is That?
#AskDrDurie: My Doctor Thinks the Myeloma Treatment is Damaging my Liver: Is That Correct?
#AskDrDurie: Is Stopping Pomalidomide After 1 Month Okay?
#AskDrDurie: Does "Big Data Analysis" Apply to Myeloma Patients?
#AskDrDurie: If Myeloma is CD 38 Positive, Shouldn't Anti-CD 38 Antibodies Work for All Patients?
#AskDrDurie: I Need to Have Surgery: Can I Do That?
#AskDrDurie: Is Partial Response Or Very Good Partial Response Good Enough?
#AskDrDurie: Can Myeloma Run In The Family?
#AskDrDurie: What About The Role Of Antibody Therapy In Myeloma?
#AskDrDurie: What Is "Off Label" Use?
#AskDrDurie: What Is Recommended for Smoldering Myeloma?
#AskDrDurie: Should I be in a Clinical Trial
#AskDrDurie: How Can Myeloma Patients Avoid Infection?
#AskDrDurie: Are There Special Precautions for Myeloma Patients in the Summer?
#AskDrDurie: Should I Be On Maintenance Therapy?
#AskDr.Durie: Is Chemobrain Real?
#AskDrDurie: What Diet Is Recommended For Myeloma Patients?
#AskDrDurie: What's New From ASCO/EHA/IMWG Summit?
#AskDrDurie: Is MGUS A Tumor, And What Is Being Done To Prevent It?
#AskDrDurie: ASCT For Younger Patients - Is Disease "Control" Sufficient?
#AskDrDurie: Can Zometa® be used alone to treat myeloma with bone disease?
#AskDrDurie: Are Cataracts a Side Effect of Treatment with Revlimid?
#AskDrDurie: How Do I Get Rid of Bone Pain?
#AskDrDurie: Is Kidney Transplant Possible for Myeloma Patients?
#AskDrDurie: Which of the new treatments are the most exciting?
#AskDrDurie: How close are we to a cure?


You might also be interested in:

What is the new Black Swan project that studies families with myeloma?

In this week’s video, Dr. Brian Durie unveils a new BSRI project which studies genetic factors (though there are few) that are linked to myeloma.

BOTTOM LINE: 

If we identify genetic factors in MM, we can refine treatments accordingly.


What is this new Black Swan project called iStopMM?

In this week’s video, Dr. Brian Durie describes how the iStopMM study aims to prevent myeloma in the entire adult population of adults who are age 40 or over in Iceland.

BOTTOM LINE: While a seemingly lofty goal, iStopMM may bridge the pathway to eliminating myeloma.


Is it worth the risk of developing a secondary cancer after ASCT?

In this week’s Ask Dr. Durie, Dr. Brian Durie discusses how to learn about your own risk factors for secondary cancers when undergoing MM treatment.

BOTTOM LINE:

Know your own risk factors and discuss the pros and cons with your doctor.


How long does it take to assess if a particular treatment is working?

In this week’s video, Dr. Brian Durie provides insight on how to assess response to various myeloma treatments.

BOTTOM LINE:

By checking M-protein levels after each cycle of treatment, we can assess the true benefits of each therapy.


How common are low platelet counts after autologous stem cell transplant?

In this week’s video, Dr. Brian Durie explains that patients should keep a close eye on their platelet counts after undergoing a stem cell transplant.

The BOTTOM LINE: 

If platelet counts drop too low, therapy adjustments should be considered.


Does immune therapy work for high-risk myeloma?

In this week’s video, Dr. Brian Durie discusses how immune therapies work in the treatment of myeloma.

BOTTOM LINE:

Best bets to fight high-risk myeloma are therapies that replace, rather than manipulate, the immune system. 


Do all myeloma patients become high-risk at some point?

In this week’s video, Dr. Brian Durie answers questions about high-risk multiple myeloma.

BOTTOM LINE:

Over time, different myeloma patterns emerge. 


What is the status of the measles vaccine trial?

In this week’s video, Dr. Brian Durie discusses the use of virus trials in the treatment of multiple myeloma.

BOTTOM LINE:

The virus trials are generating excitement. Contact the IMF to learn more.


If no treatment for multiple myeloma is recommended, is a bone marrow biopsy necessary?

In this week’s video, Dr. Durie answers a question about whether a patient should undergo a bone marrow biopsy, even if treatment is not recommended at the time.

Bottom Line: 

If you are unsure about diagnosis, treatment, or testing, consult an expert.


After relapse, I’m responding well to Rev/dex. Should I continue this treatment?

In this week's video, Dr. Brian Durie addresses if patients should continue certain treatments.

Bottom Line: 

When the disease is controlled, ongoing maintenance is still a good choice. 


Is it possible to have symptoms of myeloma in your head?

In this week's video, Dr. Brian Durie discusses how fear may lead to imagined symptoms of myeloma. 

Bottom Line:

Successful treatment will drive away symptoms that exist only in your mind.


What are the new drug trials available for patients in 2016?

In this week's video, Dr. Brian Durie talks about which new drug trials are available for patients in 2016.

Bottom Line:

Check clinicaltrials.gov or contact the IMF InfoLine @ 800-452-CURE for more info.


How does one achieve a strong communicative relationship with one’s doctor?

In this week's video, Dr. Brian Durie discusses how to develop a strong communicative relationship with your doctor.

Bottom line:

Make sure you find a doctor with a communication style that suits your needs. 


What are the key, ongoing clinical trials for myeloma patients?

In this week's video, Dr. Brian Durie answers what are the key, ongoing clinical trials for myeloma patients.

Bottom line:

Check clinicaltrials.gov or call the IMF for updates.


What are the best scans to monitor myeloma?

In this week's ask video, Dr. Brian Durie discusses what are the best scans to monitor myeloma and how it will be used for treatment.

Bottom Line:

MRI, PET scanning, and CT are the way forward for myeloma imaging tests.


Can myeloma progress after an autologous stem cell transplant (ASCT)?

In this week's video, Dr. Brian Durie the pros and cons of an autologous stem cell transplant (ASCT).

Bottom Line:

It is rare to become worse after ASCT, and its likely benefits need to be evaluated on a long-term basis.


Will any of the newly FDA-approved drugs be available for frontline therapy?

In this week's video, Dr. Brian Durie discusses if the newly FDA-approved drugs (Ninlaro, Emplicity, Darzalex) be available for frontline therapy?

Bottom Line:

When to use the new drugs requires a case-by-case discussion, with possible use in early disease stages.


What Should we know about FDA approval of Empliciti® (elotuzumab)?

In this week's video, Dr. Brian Durie discusses what patients and caregivers need to know on the recent approval of Empliciti® (elotuzumab).

Bottom Line:

Empliciti is a useful drug when used in combination with Rev/dex in a relapse setting.


What should we know about the FDA approval of Ninlaro® (ixazomib)?

In this week's video, Dr. Brian Durie discusses the recently FDA approved drug Ninlaro® (ixazomib).

Bottom Line:

Ninlaro is an important addition to the lineup of myeloma treatments.


What should we know about FDA approval of Darzalex® (daratumumab)?

In this week's video, Dr. Brian Durie discusses the first monoclonal antibody approved for myeloma treatment - Darzalex (daratumumab). 

Bottom  Line:

Darzalex is a useful drug that has some drawbacks in terms of testing


What is Ixazomib?

In this week's video, Dr. Brian Durie the new oral proteasome inhibitor ixazomib.

Bottom Line:
It will be very good for patients if ixazomib is as valuable as currently available drugs


Can DDT exposure cause myeloma?

In this week's video, Dr. Brian Durie answers the question if the insecticide DDT can cause myeloma?

Bottom Line:

We need to understand better how to prevent toxic exposure as another means of preventing myeloma


Can you help make sense of statistics?

In this week's video, Dr. Brian Durie helps make sense of the numbers and statistics in relation with your myeloma diagnosis and treatment.

Bottom Line:

The IMF will be a resource to help educate patients about statistics


What does it mean to be MRD-negative if you have high-risk 17p- myeloma?

In this week's video, Dr. Brian Durie discusses the implications of being MRD-negative if you have high-risk 17p- myeloma.

Bottom Line:

Testing will hopefully lead to improved therapies for patients with 17p- myeloma.


Do bone lesions regenerate?

In this week's video, Dr. Brian Durie answers the question do bone lesions regenerate.

Bottom Line:

Bones don't heal back to normal, but there are ways to recover functionality.


Do African Americans have an increased risk of myeloma?

In this week's video, Dr. Brian Durie discusses the question if African Americans have an incresed risk of myeloma.

Bottom Line:

Since African American are at higher risk for myeloma yet respond better to treatment, early diagnosis is the key. 


How does the IMF help accelerate new drug approvals?

In this week's video, Dr. Brian Durie answeres the question on how the International Myeloma Foundation contributes to the acceleration of new drug approvals for multiple myeloma.

Bottom Line:

The IMF's work helps expedite the progress of new drugs from trial phase to full approval.


Are statins helpful or harmful for myeloma patients?

In this week's video, Dr. Brian Durie answers the question regarding statins and its effect on myeloma patients.

Bottom Line:

Myeloma patients need to be cautious when taking statins...But not overly concerned about their impact on the myeloma itself.


What is the role of imaging for routine assessment of myeloma?

In this week's video, Dr. Brian Durie answers a patient's question regarding the importance of imaging and other tests in the routine assessment of myeloma.

Bottom line:

Set an imaging protocol, get a baseline scan and a periodic re-check.


What is the latest news about the Black Swan Research Initiative?

In this week's video, Dr. Brian Durie gives an update on the IMF's signature research project, Black Swan Research Initative.

Bottom Line:

The BSRI team is expanding worldwide and exciting progress is being made.


What is Selinexor?

In this week's video, Dr. Brian Durie discusses Selinexor, a novel, orally administered drug that is currently ongoing clinical trials.

Bottom Line:

Selinexor is a promising new type of drug that can make a difference for myeloma patients.


What are myeloma stem cells?

In this week's video, Dr. Brian Durie answers a patients question on what are myeloma stem cells.

Bottom Line:

However they originate, we need to find a way to eradicate the myeloma stem cells.   


How quickly will you see a benefit from an autologous stem cell transplant?

In this week's video, Dr. Brian Durie discusses how  quickly will a patient see a benfit from an  autologous stem cell transplant (ASCT)?

Bottom Line:

Optimal benefits are expected in 3 months, though there could be some improvements before and after that time.


What does the deletion of chromosome 17 mean?

In this week's video, Dr. Brian Durie discusses how the deletion of chromosome 17 mean to myeloma patients.

Bottom Line:

Chromosome 17 deletion could mean you need extra care and treatment.


Should all myeloma patients be screened for amyloidosis?

In this week's video Dr. Brian Durie answers Laura Mooney's question about amyloidosis and if myeloma patients should be screened for it. Laura is the leader of the Staten Island Support Group.

Bottom Line:

Keep amyloidosis testing on your doctor's check list.


Can weakness, dizziness and other symptoms be caused by a Vitamin B12 deficiency?

In this week's video, Dr. Brian Durie answers a question if the symptoms of Vitamin B12 deficiency is an effect of multiple myeloma treatment.

Bottom Line:

Look for other issues that could be causing symptoms that might be easily corrected.


Should you have a stem cell transplant even after a partial response to treatment?

In this week's video, Dr. Brian Durie discusses if a patient should have a stem cell transplant even after partial response to treatment.

The Bottom Line:

Even after partial remission stick with the plan.


How do I find a myeloma specialist in my area?

In this week's video, Dr. Brian Durie answers the question on how to find a specialist in an area and what steps to take if there are none.

Bottom Line:

Doctors, patients, and support groups will all help guide you to the best outcome.


What kinds of scan can determine if bone pain indicates new myeloma disease?

In this week's video, Dr. Brian Durie talks about the different imaging scans that can be used to determine if bone pain indicates new myeloma disease.

Bottom line:

It's very important for every patient to know via repeated scanning if new bone pain is significant.


How common is toxoplasmosis infection?

In this week's video, Dr. Brian Durie tackles the question on how common toxoplasmosis is and how multiple myeloma patients can protect themselves.

The Bottom Line: Patients need to work with their doctors to detect infections and make sure they are treated.


What are the practical details of FISH testing?

In this week's video, Dr. Brian Durie discusses the practical details of Flourescent In Situ Hybridization (FISH) testing.


Whats the latest update on the Black Swan Research Initiative®?

In this week's video, Dr. Brian Durie gives an update on the exciting developments happening on the Black Swan Research Initiative®.

 


Is the combination of Kyprolis, Cytoxan and dexamethasone available as a treatment?

In this week's video, Dr. Brian Durie answers a patient's question if the combination of Kyprolis, Cytoxan, and dexamethasone is available as a treatment.


Are veterans with myeloma a unique population?

In this week's video, Dr. Brian Durie answers the question "Are veterans with myeloma a unique population?" Dr. Durie also talked about the challenges that veterans face to get the best care available to them. For more information about veterans with myeloma you can visit: www.veterans.myeloma.org .


How does myeloma affect the immune system?

In this week's video, Dr. Brian Durie discusses how does myeloma affect the immune system and what can be done for the iHommune system to work better.


What is IVIG?

In this week's #AskDrDurie video, IMF Chairman Dr. Brian Durie discusses how Intravenous Immunogloblin is being used as a treatment option for multiple myeloma.


Is chiropractic care an option for patients with myeloma?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses the risks that can come with chiropractic care for patients with myeloma. He also offers some alternative therapeutic options for those who need them.


Does pomalidomide work on a myeloma patient that has not had a response with other iMiDs?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses the success a myeloma patient can have with pomalidomide, even if that patient has not had a response with other drugs in the iMiD category.


When will the first monoclonal antibody be approved?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses the progress being made with monoclonal antibodies being used to treat myeloma. He highlights three specific ones (daratumumab, Sanofi’s SAR compound, and elotuzumab) and discusses why each is promising.


If stringent complete remission is achieved, is maintenance therapy still required?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie offers his take on whether or not maintenance is recommended for a patient who has already achieved a stringent complete remission (SCR) with his or her myeloma.


What are myeloma treatment options for a patient with bipolar disorder?

In this week’s episode of #AskDrDurie, IMF Chairman Dr. Brian Durie looks at the factors of myeloma that affect the choice of treatment, including the type of myeloma and any chromosome abnormalities, as well as genetic testing done on the patient.


Does the type of myeloma impact the choice of treatment?

In this week’s episode of #AskDrDurie, IMF Chairman Dr. Brian Durie looks at the factors of myeloma that affect the choice of treatment, including the type of myeloma and any chromosome abnormalities, as well as genetic testing done on the patient.


Dr. Durie, what is your perspective on the discussion about the cost of cancer drugs?

IMF Chairman Dr. Brian Durie weighed in on the high cost of cancer drugs after the recent article in Mayo Clinic Proceedings. He discusses what needs to be done within the healthcare system to better serve the patients.


What is the recommended use of Biaxin in patients with myeloma?

In this episode of the IMF's weekly web series, #AskDrDurie, IMF Chairman Dr. Brian Durie discusses his recommendation for use of the antibiotic Biaxin for patients with myeloma.


What is the typical speed of improvement in the Freelite and protein levels with myeloma treatment?

In this new episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses how fast a myeloma patient would see improvement in both Freelite and protein levels with treatment such as three-drug combinations.


What are some treatment options for the t(4;14) abnormality?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses treatment options available for those myeloma patients with the t(4;14) abnormality, including IMiDs, next-generation proteasome inhibitors, novel combination therapies, and autologous stem cell transplants.


What does ‘dysplasia’ mean within the bone marrow report?

In this episode of the IMF’s weekly web series, #AskDrDurie, IMF Chairman Dr. Brian Durie explains what dysplasia means when it shows up on a bone marrow report.


Should gadolinium be used as part of MRI testing?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses the use of gadolinium in MRI testing, specifically for patients with abnormal kidney function.


What is the M protein?

This week, Dr. Brian Durie of the IMF answers a patient's question about the M protein and how levels are affected by time and treatment.


If bone density is low, does that mean myeloma is present?

In this week's episode of #AskDrDurie, IMF Chairman Dr. Brian Durie answers a patient's question about levels of bone density and how they connect to myeloma.


What is the 17p deletion?

In this week’s episode of #AskDrDurie Dr. Brian Durie discusses the importance of the 17p deletion chromosome abnormality when remission has been achieved.


#AskDrDurie: What’s new with the Black Swan Research Initiative®?

In the first episode of the new year, Dr. Brian Durie of the IMF looks back on the progress of a signature project, the Black Swan Research Initiative® to discuss major accomplishments in 2014.


#AskDrDurie: What does IMWG’s new diagnostic criteria mean for myeloma patients?

In this episode of #AskDrDurie, Dr. Brian Durie talks about the new diagnostic guidelines and tests that can be used to diagnose myeloma early, before CRAB features have emerged. These criteria have been published in a new publication available on myeloma.org.


#AskDrDurie: Why wasn’t panobinostat approved?

In this episode of #AskDrDurie, Dr. Brian Durie of the IMF answers a  patient's question about why the recent FDA ODAC hearing rejected the use of new drug panobinostat for myeloma. He also discusses other HDAC inhibitors that are currently in development.


#AskDrDurie: What's new at ASH 2014

In this week’s special #AskDrDurie episode, Dr. Brian Durie of the IMF takes a look at the December 2014 ASH (American Society of Hematology) meeting in San Francisco. He previews what abstracts will be presented and talks about news to expect out of the meeting.


#AskDrDurie: Can Cytoxan cause heart damage?

In this week's #AskDrDurie, the IMF's Dr. Brian G.M. Durie answers a patient's concern regarding myeloma treatment and heart damage--specifically when it comes to the drug Cytoxan.


#AskDrDurie: What happens to stem cells once they are harvested?

In this week's episode of #AskDrDurie, Dr. Brian G.M. Durie of the IMF answers a patient's question regarding stem cells. If they are harvested in a specific facility, can they be moved and stored elsewhere later?
 
Find out the answer in this video!


#AskDrDurie: Can the Hevylite™ test be used to monitor IgA myeloma?

In this week’s episode of #AskDrDurie, Dr. Brian Durie of the IMF answers a patient question regarding IgA myeloma and tests used to monitor it, specifically the Hevylite™ test. Watch this video to learn all about Hevylite.


#AskDrDurie: Is it possible to have short remissions without high-risk features?

Inspired by last week's #AskDrDurie episode in which Dr. Brian Durie of the IMF explained the definition of remission when it comes to  myeloma patients, this new episodes is a follow-up. Here, Dr. Durie explains why a myeloma patient might experience a short remission period, even if high-risk features have not been identified.


#AskDrDurie: What is remission?

In the latest episode of #AskDrDurie, Dr. Brian Durie of the IMF explains what remission means for myeloma patients.


#AskDrDurie: How does the IMF contribute to the myeloma community?

In the latest episode of #AskDrDurie, Dr. Brian Durie addresses a patient who has just learned about the IMF by explaining three key contributions the IMF makes to myeloma research and education.


#AskDrDurie: What is Selinexor

In this week's episode of #AskDrDurie, Dr. Brian Durie of the IMF takes a question from a patient who has relapsing myeloma and is wondering about the new drug Selinexor. Dr. Durie explains what the drug is and how it can be used in myeloma.


#AskDrDurie: Is autologous stem cell transplant still recommended?

In this episode of the IMF’s #AskDrDurie web series, Dr. Brian Durie talks about when and for what kind of myeloma patient an autologous stem cell transplant (ASCT) is recommended.


#AskDrDurie: Has there been any change in recommendations used to treat bone disease in myeloma?

In this week's episode of #AskDrDurie, the IMF's Chairman Dr. Brian Durie answers a patient's question regarding how bone disease in myeloma is treated. He discusses bisphosphonates such as Aredia and Zometa and what the current recommendations are.


#AskDrDurie: If Pomalyst does not produce a full response, what are my options?

In this episode of #AskDrDurie, Dr. Brian Durie explores options for myeloma treatment if a patient isn’t receiving a full response from Pomalyst.


#AskDrDurie: Is there a test available for measuring Minimal Residual Disease, what we call MRD?

In this week's #AskDrDurie, the IMF's Dr. Brian Durie answers a very important question regarding the tests available for measuring Minimal Residual Disease. As you may know, the IMF's Black Swan Research Initiative(R) has been evaluating a new flow test method for this, and it is becoming a new benchmark.


#AskDrDurie: How can Revlimid’s diarrhea side effect be handled?

In this episode of #AskDrDurie, the IMF's Dr. Brian Durie answers a patient's question about dealing with a specific side effect from Revlimid.


#AskDrDurie: Is it okay to take vitamin B12 on the same day as Velcade?

In this episode of #AskDrDurie, Dr. Brian Durie of the IMF answers a myeloma patient’s question about taking a supplement like vitamin B12 on the same day as Velcade.


#AskDrDurie: What are the important aspects of different types of imaging, such as regular x-rays, MRI, CT, and PET?
In this week's #AskDrDurie episode, Dr. Brian Durie of the IMF explains the difference between x-rays, MRI, CT, and PET image scans. Each one has its place in detecting myeloma, and he walks viewers through each.

#AskDrDurie: Should I have an ASCT if I've been through therapy and am in remission?

In this week's #AskDrDurie, IMF Chairman and Co-Founder, Dr. Brian Durie answers a patient's inquiry about the benefits and necessity of having an autologous stem cell transplant (ASCT) if treatment for myeloma has already been completed, with remission as the result.


#AskDrDurie: How can myeloma suddenly go from standard to high risk?
In this episode of #AskDrDurie, IMF Co-Founder and Chairman Dr. Brian G.M. Durie answers a patient submitted question regarding receiving an initial diagnosis of standard myeloma, having treatment, and then being told the myeloma was high risk. He explains when and why that can happen and discusses different kinds of testing involved.

#AskDrDurie: Can a low white blood cell count be enough to trigger a need for myeloma therapy?

In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie talks about what a low white blood cell count means when it comes to myeloma.


#AskDrDurie: Does age make a difference in selecting myeloma treatment?

In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie discusses the important factors one must consider when selecting individualized treatment for myeloma.


#AskDrDurie: Is MRI testing important to see if treatment is necessary for smoldering myeloma?

In this episode of #AskDrDurie, Dr. Brian Durie discusses the importance of MRI testing, specifically when it comes to patients with smoldering myeloma.


#AskDrDurie: Are there maintenance therapy recommendations for myeloma patients with t(4;14)?

In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie addresses a question about what kind of maintenance therapy is recommended for those myeloma patients who have the t(4;14) chromosome abnormality.


#AskDrDurie: Are clinical trials part of the Black Swan Research Initiative(R), and if so, how can I participate?

In this episode of #AskDrDurie, Dr. Brian Durie, IMF Chairman and Co-Founder, talks about the Black Swan Research Initiative(R)'s various clinical trials and how eligible patients can get more information and potentially participate in them.


#AskDrDurie: How does the new flow cytometry testing for MRD compare to molecular testing?

In this episode of #AskDrDurie, Dr. Brian G.M. Durie, IMF Chairman and Co-Founder, discusses the sensitivity and accessibility of the flow cytometry method of MRD testing. 


#AskDrDurie: Are PET/CT scans useful for a patient with MGUS?

In this episode of #AskDrDurie, Dr. Brian G.M. Durie, IMF Chairman, explains what MGUS means and why PET/CT scans are the most effective way to exclude unsuspected lesions that may occur in patients.


#AskDrDurie: In light of Tom Brokaw's recent myeloma diagnosis, is better early screening required?"

In this episode of #AskDrDurie, Dr. Brian G.M. Durie, IMF Chairman, discusses the importance of early detection screenings in order to diagnose myeloma. Find out why there is a constant need for awareness and monitoring of any changes in test results.


#AskDrDurie: Should Patients With Similar Types of Myeloma Form Separate Support Groups?

#AskDrDurie: If Myeloma Is Diagnosed, Is It Okay to Start With A Holistic Type of Approach First?

#AskDrDurie: My Maintenance was Stopped Because the Side Effects were Too Bad. How Common is That?

#AskDrDurie: My Doctor Thinks the Myeloma Treatment is Damaging my Liver: Is That Correct?

#AskDrDurie: Is Stopping Pomalidomide After 1 Month Okay?

#AskDrDurie: Does "Big Data Analysis" Apply to Myeloma Patients?

#AskDrDurie: If Myeloma is CD 38 Positive, Shouldn't Anti-CD 38 Antibodies Work for All Patients?

#AskDrDurie: I Need to Have Surgery: Can I Do That?

#AskDrDurie: Is Partial Response Or Very Good Partial Response Good Enough?

#AskDrDurie: Can Myeloma Run In The Family?

#AskDrDurie: What About The Role Of Antibody Therapy In Myeloma?

#AskDrDurie: What Is "Off Label" Use?

#AskDrDurie: What Is Recommended for Smoldering Myeloma?

#AskDrDurie: Should I be in a Clinical Trial

#AskDrDurie: How Can Myeloma Patients Avoid Infection?

#AskDrDurie: Are There Special Precautions for Myeloma Patients in the Summer?

#AskDrDurie: Should I Be On Maintenance Therapy?

#AskDr.Durie: Is Chemobrain Real?

#AskDrDurie: What Diet Is Recommended For Myeloma Patients?

#AskDrDurie: What's New From ASCO/EHA/IMWG Summit?

#AskDrDurie: Is MGUS A Tumor, And What Is Being Done To Prevent It?

#AskDrDurie: ASCT For Younger Patients - Is Disease "Control" Sufficient?

#AskDrDurie: Can Zometa® be used alone to treat myeloma with bone disease?

#AskDrDurie: Are Cataracts a Side Effect of Treatment with Revlimid?

#AskDrDurie: How Do I Get Rid of Bone Pain?

#AskDrDurie: Is Kidney Transplant Possible for Myeloma Patients?

#AskDrDurie: Which of the new treatments are the most exciting?

#AskDrDurie: How close are we to a cure?